Immature Dengue Virus: a Veiled Pathogen?
Overview
Authors
Affiliations
Cells infected with dengue virus release a high proportion of immature prM-containing virions. In accordance, substantial levels of prM antibodies are found in sera of infected humans. Furthermore, it has been recently described that the rates of prM antibody responses are significantly higher in patients with secondary infection compared to those with primary infection. This suggests that immature dengue virus may play a role in disease pathogenesis. Interestingly, however, numerous functional studies have revealed that immature particles lack the ability to infect cells. In this report, we show that fully immature dengue particles become highly infectious upon interaction with prM antibodies. We demonstrate that prM antibodies facilitate efficient binding and cell entry of immature particles into Fc-receptor-expressing cells. In addition, enzymatic activity of furin is critical to render the internalized immature virus infectious. Together, these data suggest that during a secondary infection or primary infection of infants born to dengue-immune mothers, immature particles have the potential to be highly infectious and hence may contribute to the development of severe disease.
Shaikh S, Sandeep Chary P, Mehra N Inflammopharmacology. 2025; .
PMID: 39976669 DOI: 10.1007/s10787-025-01655-8.
Thrombocytopenia in dengue infection: mechanisms and a potential application.
Khazali A, Hadrawi W, Ibrahim F, Othman S, Nor Rashid N Expert Rev Mol Med. 2024; 26:e26.
PMID: 39397710 PMC: 11488332. DOI: 10.1017/erm.2024.18.
Mechanisms of antibody-dependent enhancement of infectious disease.
Wells T, Esposito T, Henderson I, Labzin L Nat Rev Immunol. 2024; 25(1):6-21.
PMID: 39122820 DOI: 10.1038/s41577-024-01067-9.
Liu H, Li Z, Reindl T, He Z, Qiu X, Golden R Nat Commun. 2024; 15(1):5179.
PMID: 38898037 PMC: 11187112. DOI: 10.1038/s41467-024-49161-9.
Xinyang flavivirus, from ticks in Henan Province, China, defines a basal, likely tick-only clade.
Wang L, Cheng Q, Newton N, Wolfinger M, Morgan M, Slonchak A J Gen Virol. 2024; 105(5).
PMID: 38809251 PMC: 11165663. DOI: 10.1099/jgv.0.001991.